Navigation Links
IPC The Hospitalist Company Acquires Arizona Practice
Date:3/9/2009

Expands Presence in Greater Phoenix Market

NORTH HOLLYWOOD, Calif., March 9 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national physician group practice company, announced today that it has acquired Acclaimed Internal Medicine, PLLC (AIM) of Mesa, Arizona. The acquisition represents a continued expansion into the greater Phoenix market, where IPC has already established a significant presence. IPC expects to add approximately 55,000 patient encounters annually from the acquisition of AIM.

Adam Singer, M.D., IPC's Chairman and CEO, said, "As part of our overall growth strategy, we are always looking for opportunistic in-market acquisitions to deepen our penetration of existing markets. AIM is an ideal fit, as it enables IPC to leverage its core strengths to the benefit of AIM's clients, many of whom we already serve. For example, IPC and AIM each currently have practices at Banner Baywood Medical Center; together, the two existing practice groups can work to improve coverage, focus on quality, and increase patient satisfaction. Additionally, IPC will utilize its existing regional management infrastructure to support this combined practice."

Saul Blair, IPC's Executive Director for the Phoenix region, commented, "AIM's providers have practiced and will continue to practice in Banner Baywood and nearby facilities. The combining of AIM's operations with IPC will give us greater capability to focus on operational and quality initiatives, enhance clinical communications, and coordinate recruitment efforts."

The AIM owners, Drs. Pesari, Horeish and Martinez, will remain active in the practice group as IPC employees. Dr. Pesari, a former IPC hospitalist, remarked, "I am delighted to be returning to IPC after a several year hiatus. I know from experience the complete infrastructure that IPC brings to the table, and it is just what our practice needs to take the next steps in its development."

About IPC The Hospitalist Company, Inc.

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading national physician group practice company focused on the delivery of hospitalist medicine services. IPC's physicians and affiliated providers manage the care of hospitalized patients in coordination with primary care physicians and specialists. The Company provides its hospitalists with the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of inpatient care in the facilities it serves. For more information, visit the IPC website at www.hospitalist.com.

    Media Contact:                            Investor Contacts:
    Scott Public Relations                    The Ruth Group
    Elaine Murphy                             Stephanie Carrington/Amy Glynn
    818.610.0270                              646.536.7017/7023
    elaine@scottpublicrelations.com           scarrington@theruthgroup.com
                                              aglynn@theruthgroup.com

'/>"/>
SOURCE IPC The Hospitalist Company, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Spokane Hospitals Engage Sound Inpatient Physicians(TM) as Hospitalists in Spokane
2. IPC The Hospitalist Company Adopts E-Proxy to Reduce Environmental Impact
3. IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results
4. IPC The Hospitalist Company Receives Best IPO Award from Los Angeles Venture Association
5. IPC The Hospitalist Company Acquires Missouri Practice Group
6. IPC The Hospitalist Company, Inc. to Present at 27th Annual J.P. Morgan Healthcare Conference
7. Physician Staffing Trends and Hospitalist Jobs Fuel Growth at Locum Leaders
8. IPC The Hospitalist Company Acquires Two Florida Practices
9. Dr. Steven Liu, Founder of Ingenious Med, Recognized as a Leading Hospitalist by the American College of Physicians
10. IPC The Hospitalist Company Reports Record Third Quarter 2008 Results
11. IPC The Hospitalist Company, Inc. to Present at the 2008 Annual Credit Suisse Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... 2016 , ... Research has shown that building shame resilience ... and level of relapse. , At the 2016 iaedp Symposium, the ... the critical tasks of the recovery phase and beyond including relapse prevention and ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... availability of the company's lighter, sleeker next generation LYNX VR Indoor Trainer with ... , Improvements in design and manufacturing not only reduce the weight of the ...
(Date:2/5/2016)... ... , ... The event is being held on April 7, 2016 from 5:30 ... Over Parkinson’s will fund nearly $100,000 for research for the care and cure of ... and is the architect of this informative event to raise awareness and funds for ...
(Date:2/5/2016)... ... February 05, 2016 , ... Looking for a last-minute Valentine’s Day ... tips of your toes. Foot massage, whether administered by a professional masseuse or a ... The American Board of Multiple Specialties in Podiatry (ABMSP) has taken the ...
(Date:2/5/2016)... Florida (PRWEB) , ... February 05, 2016 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – is poised to once again host, Swirl, A Wine Tasting Event at ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Worldwide Radiology ... significant growth as next generation systems provide a ... radiology for cancer surgery. New systems pinpoint the ... that has been such a problem previously, limiting ... Radiosurgery robots take cancer surgery far beyond what ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... Summary Global Markets Direct,s, ,Wegener Polyangiitis - ... the Wegener Polyangiitis,s therapeutic pipeline. This report ... Wegener Polyangiitis, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:2/4/2016)... , Feb. 4, 2016 Global ... competitive market to drive long-term market growth ... common set of chronic disorders that affect 5–7% ... in terms of their symptoms and key patient ... dysregulation of immune pathways and an inappropriate immune ...
Breaking Medicine Technology: